Milestone Scientific INC Form 4 insider transactions

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., reported the sale of 194,427 shares of common stock across three transactions in October 2025.

BP4 S.r.l., a director and 10% owner of Milestone Scientific Inc., reported selling 64,034 shares of common stock in late October 2025.

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc. (MLSS), reported the sale of 50,158 shares of common stock through a pre-arranged Rule 10b5-1 trading plan.

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., reported the sale of 40,000 common shares through a pre-arranged 10b5-1 trading plan.

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., reported selling 19,210 shares of common stock.

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., reported the sale of 10,000 shares of common stock.

BP4 S.r.l., a director and 10% owner of Milestone Scientific Inc., reported a pre-planned sale of 10,000 common shares.

BP4 S.r.l., a director and 10% owner of Milestone Scientific Inc., has filed a Form 4 detailing pre-scheduled sales of 92,900 shares of common stock in July 2025 under a Rule 10b5-1 trading plan.

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., reported multiple sales of common stock totaling 27,882 shares between June 23 and June 30, 2025, reducing its beneficial ownership to 9,417,608 shares.

BP4 S.r.l., a significant shareholder and director of Milestone Scientific Inc., reported the sale of 11,749 shares of common stock across two transactions in mid-June 2025.

BP4 S.r.l., a director and 10% owner of Milestone Scientific Inc., reported the sale of 23,797 shares of common stock at $0.902 per share.

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc. (MLSS), reported the sale of 50,366 shares of common stock across two transactions in early June 2025.

BP4 S.r.l., a 10% owner and director of Milestone Scientific Inc., has reported the sale of 87,055 shares of common stock across two transactions in early June 2025.

BP4 S.r.l., a significant 10% owner and director of Milestone Scientific Inc. (MLSS), reported the sale of 14,000 shares of common stock in early June 2025.

BP4 S.r.l., a director and 10% owner of Milestone Scientific Inc. (MLSS), reported the sale of 22,118 shares of common stock across two transactions in late May and early June 2025.

BP4 S.r.l., a 10% owner of Milestone Scientific Inc. (MLSS), reported the sale of 17,617 shares of common stock over two days in late May 2025.

Director Michael McGeehan of Milestone Scientific Inc. sold 20,000 shares of common stock at an average price of $0.7766 on December 19, 2024.

Director Leonard Osser sold 107,984 shares of Milestone Scientific Inc. at $0.93 per share on October 22, 2024.

Director Michael McGeehan sold 209 shares of Milestone Scientific Inc. on September 24, 2024.

Director Michael McGeehan of Milestone Scientific Inc. reports selling shares of common stock on September 19 and 20, 2024.

Director Benedetta I. Casamento acquired 134,834 shares of Milestone Scientific Inc. common stock on August 28, 2024, as part of her annual director's fee.

Director Michael McGeehan acquired 123,560 shares of Milestone Scientific Inc. as part of his annual director's fee.

Neal Goldman, a director at Milestone Scientific Inc., acquired 134,832 shares of common stock on August 28, 2024, as part of his annual director's fee.

Director Leonard Osser acquired 112,356 shares of Milestone Scientific Inc. common stock on August 28, 2024, as part of his annual director's fee.

Giandomenico Trombetta, a director at Milestone Scientific Inc., acquired 112,356 shares of common stock at $0.89 per share on August 28, 2024, as part of his annual director's fee.

Director Leonard Osser of Milestone Scientific Inc. sold 141,913 shares of common stock at $0.95 per share on August 21, 2024.

Director Neal Goldman acquired 22,127 shares of Milestone Scientific at $0.55 per share, increasing his total holdings to 1,771,026 shares.

Director Neal Goldman of Milestone Scientific Inc. reports acquiring 56,065 shares of common stock at $0.54 per share on April 22, 2024.